German uni clinic deaths add to case for better patient screening in ABR fight
This article was originally published in Clinica
The tragedy of the Ebola virus is not just its broad scale human consequences, but that it was avoidable. Easy to be wise after the event, and lazily easy to ascribe all blame to those whose task is to manage finite preventive care resources. But while Ebola is still very much ongoing, to fail to draw the lessons from an event of such proportions would be inexcusable.
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data via automation and IT means that progress might change at last. How the tests are paid for remains an issue. The future of POC was the theme of an investor discussion at the first DxPx conference, held during the Medica 2019 event in Germany.
For many, the EU MDR is coming too fast, yet several of its crucial elements are not yet in place. Germany’s liberal FDP MPs say the national government needs to make a stand and address a European issue that will impact German patients. In a motion to parliament, the MPs propose fast-tracking for innovative products and measures to keep orphan devices in circulation.